The properties of fibrinogen extracted by a precipitation method using glycine at ambient temperatures near neutral pH are described. The simple and reproducible method gives a 73 % yield of high purity plasminogen-free fibrinogen in 45 minutes from small volumes of plasma. The protein extract was labelled with 1251 using chloramine-T under conditions optimal for fibrinogen stability. The extraction procedure, radio-iodination, desalting, and sterilization take only 70 minutes for completion from the time donor blood is received in the laboratory. The methods, using a specially developed extraction vessel and desalting/sterilizing column, can be used in a small hospital laboratory. Autologous fibrinogen can thus be extracted from patients' blood, eliminating the risk of transmitting hepatitis when it is re-administered. The autologous material, which is 97 % clottable and contains less than 0 05 % free iodide, is being routinely used as a diagnostic tool in the detection of deep vein thrombosis. The high purity of the preparation facilitates metabolic studies and in vitro experimental work. In vivo results show a mean half-life in three normal volunteers of 3 95 days and a catabolic rate of 25-23 % per day with the extravascular space estimated as 24-86 %. In 30 surgical patients an expected reduced half-life in plasma was determined with a mean of 3*1 days.
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The highly sensitive and specific method for the detection of deep vein thrombosis, that of the 125I fibrinogen technique, has been criticized because of the risk of transmitting serum hepatitis when pooled human plasma is used for the extraction of fibrinogen (Kakkar, 1972; Hume, 1973) . Hicks and Hazell (1973) have reported the use and follow-up of this technique in large numbers of paJents and there seems little evidence to support this criticism although their techniques have been questioned (Goudie et al, 1973) . This hepatitis risk has prevented its widespread use as a diagnostic tool in both Britain and, by legislation, the United States. The use of autologous plasma would eliminate the risk of introducing hepatitis. However, previous methods suitable for extracting purified autologous fibrinogen from plasma have been lengthy or too complex for routine diagnostic use (Bettigole et al, 1969; Ingraham et al, 1969; Peabody et al, 1974) . The few rapid methods that have been reported contain protein and free radio-iodide contaminants, making them unsuitable for metabolic studies or Received for publication 8 January 1976 laboratory assays (Roberts et al, 1972; Hagan et al, 1974) . Materials used for previous metabolic studies suffer from the same faults (McFarlane, 1963; Takeda, 1966; Collen et al, 1972; Bradley and Hickman, 1975) . Kazal et al (1963) showed that glycine in an aqueous system has a salting-in action on all plasma proteins with the exception of fibrinogen and a cold insoluble beta globulin; by using controlled conditions of temperature and glycine concentration fibrinogen alone could be precipitated. This simple precipitation procedure produced a high yield of clottable protein with little degradation or contamination of the product (Walker and Catlin, 1971) . The removal of plasminogen during fibrinogen extraction from plasma has proved particularly dificult, although Blomback and Blomback (1957) showed glycine to have a greater solubilizing effect on plasminogen than on fibrinogen and produced a fibrinogen low in the pro-enzyme. The addition of zinc ions (Zn2+) as well as E-amino-n-caproic acid (EACA) to samples during preparation has been shown by Brown (1972) to assist the removal of fibrinolysis has ensured the absence of fibrinogen degradation product contaminants and has stabilized the preparation.
The present study details the methods for extraction, radio-iodination, desalting, and sterilization of an autologous fibrinogen suitable for metabolic studies. The in vitro properties and in vivo behaviour are outlined.
Material and Methods

MATERIAL FOR EXTRACTION OF FIBRINOGEN
The extraction procedure was carried out at room temperature (not less than 20°C) and has been centred around the separation vessel (fig 1) (Hawker, 1975 Saline citrate 1 litre of aqueous solution containing 5-75 g trisodium citrate 2H20 and 27-25 g sodium chloride adjusted to pH 7 0 with IN HCI.
METHOD OF EXTRACTION
Fifteen millilitres of blood were taken by clean venepuncture and diluted with 4'5 ml of 3-8 % aqueous trisodium citrate. After centrifugation at 3000 x g for 5 min, 8 ml of the plasma was magnetically mixed with 1 g powdered glass and 2-0 ml anticoagulant solution in the separation vessel. 1-47 g glycine was dissolved in the mixture and after 8 min of constant stirring the supernatant was drawn to waste through the sintered base of the separation vessel. To prevent the sintered disc becoming clogged by the gelatinous precipitate stirring was stopped and 15 s delay was allowed for the powdered glass to settle before the supernatant was drawn off. The glycine concentration at precipitation is equivalent to 1-79 M. The retained precipitate was washed repeatedly with the washing solution (1 98 M glycine) before the vessel was returned to the stirring assemblage. Ten millilitres of diluted anticoagulant solution was added, followed, after 8 min of stirring, by 1-47 g glycine to reprecipitate the fibrinogen. After precipitate collection and washing as before, this purified precipitate was redissolved in 5 ml of saline citrate pH 7 0 and was collected after being pulled through the sintered disc.
The To a prepared desalting column with attached 19 sterilized filter unit and bottle (containing a 0-2 ,u Gelman GA8 filter) 1 0 ml of a one plus one dilution of donor plasma in saline citrate was carefully added to the Sephadex surface followed by the contents of rCINE the fibrinogen-labelling tube (also 1 0 ml). The plasma had a twofold function: to prevent non specific adsorption of the labelled fibrinogen to both the Sephadex column and filter; to prevent biochemical changes and radiation damage to the fibrinogen in solution.
The filter unit consisted of a Swinnex 13 type 70
Millipore filter holder modified for the retention of Sephadex gels and the sterilization of filtrates during ,BELLED centrifugation (Hawker, 1974 were scanned daily with a one-inch NaI crystal detector for accumulating radioactivity, ie, fibrin 1, 60 x g deposition, indicative of thrombus formation (Kakkar, 1972) .
Results
IN VITRO
The extracted material was shown to contain only one protein species, fibrinogen, by immunoelectrophoresis, double diffusion (Wolf and Walton, 1965) , and SDS polyacrylamide gel electrophoresis (Weber and Osborn, 1969) . The material had a single ultracentrifugation peak S20w of 6-8 (MSE Centriscan 75). The absence of plasminogen was confirmed by the use of fibrin plates (Wolf, 1968) and by clot lysis tests which showed the inability of a clotted specimen to lyse during five days at 370C even after the addition of plasminogen activators.
Quick's one-stage prothrombin time was used to determine fibrinogen stability after extraction; the clotting time remained constant after 6 hours at 37°C. In all samples, factor XIII was present as determined by the inability of 5 M urea to lyse a clot, unless Mersalyl (Evans) was added before clot formation.
The extinction coefficient was calculated from gravimetric analysis to be E28onm 1°Oc of 15*5 which is in agreement with the literature (Dellenback and Chien, 1970) .
The percentage yield was 73 ± 8 % as calculated by comparison of clot weight of fibrinogen with that of donor plasma.
Gel permeation studies were carried out on iodinated samples using continuous flow monitoring over a 2-inch thallium-activated Nal crystal detector. In all cases the eluent was saline citrate, pH 7T0, containing 0 05 % Tween 20 to prevent non-specific adsorption of proteins to the dextran gels.
The percentage labelling with 125I was determined as 30% to 60% by G25 chromatography. The free iodide content was shown by chromatography on G25 Sephadex to be less than 0 05 % in all samples after passage through the desalting and sterilizing unit. Gel chromatography on Sephadex G200 showed only one peak of In 30 surgical patients, for whom there are complete data, a fibrinogen halflife of 74-8 ± 11-37 hours (3-12 ± 0-47 days) and a decreased value for the extravascular space (14-35 %) was calculated. Figure 4 shows the typical plasma clearances of two recipients of autologous fibrinogen. Quoted figures show the very high degree of correlation (r), the calculated plasma half-life (TO), and the estimate of extravascular space (a). The difference in radioactive content between a one-hour sample and that taken 15 minutes after injection was only 1-29 % in a medical patient with bilateral deep vein thrombosis. External monitoring using a counter-ratemeter (J & P Engineering Ltd, Reading) and hand-held crystal detector was used to localize radioactivity in patients (Kakkar, 1972) . The injected 1251 fibrinogen was shown to be incorporated into thrombi developing in the deep veins of the legs, and a raised radioactive count over surgical wounds was seen, consistent with fibrin deposition at this site. Autoradiographs of histological sections of thrombi removed from patients clearly demonstrated the incorporation of radioactivity in intercellular strands corresponding to the fibrin network. An association of radioactivity with leucocytes ( Edwards and Haynes, 1974) was only found in specimens removed after a period of several biological half-lives of fibrinogen, suggesting that leucocytes were responsible for the removal, by phagocytosis, of degradation products .
Discussion
Fibrinogen extracted and radio-iodinated by the above method has several advantages over the commercially available material. (a) The use of patients' own plasma eliminates the risk of spreading hepatitis; (b) the material can be used for metabolic studies; (c) the in vivo half-life is that of native fibrinogen, therefore less radioactivity needs to be administered to achieve good results; (d) the preparative method is extremely reproducible as are the in vivo and in vitro results; (e) it is cheaper to produce, and the costly delays and wastage of the radiopharmaceutical available from suppliers are avoided. The half-life in normal subjects of 3-95 days compares very favourably with that reviewed in the literature for humans (Regoeczi, 1971) . The plotted data confirm the absence of degraded or denatured material; and the estimate of the extravascular compartment by extrapolation is also comparable with that previously reported.
The shortened intravascular half-life for fibrinogen calculated for surgical patients is to be expected (Hickman, 1971) since the continual formation and lysis of fibrin at the wound site is taking place at a greater rate than in normal states. The partitioning into extravascular space probably does not occur since synthesis of fibrinogen will be extremely rapid and there will be an increased intravascular pool. The underestimate of extravascular space of 14-35 % in surgical patients as compared with 24-86% in group.bmj.com on April 19, 2017 -Published by http://jcp.bmj.com/ Downloaded from normal subjects may not represent extravascular space at all but merely partitioning into a third compartment, ie, the wound or thrombus site.
Fibrinogen is generally labelled by the method of McFarlane (1963) or by one of the many modifications. The methods all require the use of unstable iodine monochloride, accurate pH adjustment, and microlitre volume handling of a very high specific activity radioactive iodide.
The chloramine-T method originated by Hunter and Greenwood (1962) (1972) showed, in a separation technique on Sepharose 4B, that fibrinogen labelled by these methods and by the electrolytic method showed different chromatographic properties, and that the ratio of chloramine-T to tyrosine residues in the labelling mixture was critical if aggregation of fibrinogen was to be avoided.
There are two possible explanations for the differing results of our work and that of these previous authors:
(a) the absence of phosphate ions which, if present, would remove calcium ions necessary for the stability of fibrinogen preparation (Wolf, 1975) . Krohn et al (1972) (1973) . (b) a reduction in the chloramine-T concentrations used in the labelling reaction as judged by the molar ratio of chloramine-T to tyrosine. In our work we have minimized this ratio (max. molar ratio 1 2) and increased the reaction volume of solution from approximately 75 ul to 850 IlI. Only by using conditions optimal for fibrinogen stability and ignoring labelling yields have we produced an aggregate-free material. The method described in this paper uses chloramine-T with volumes and specific activities of radiolabel that can be handled more comfortably in a small hospital laboratory than that of the iodine monochloride method.
Sterilizing filtration of easily aggregated proteins, eg, fibrinogen, can be a source of large losses and low yields. We have tested methods of filtration of fibrinogen to remove bacterial contaminants and shown that losses can be avoided by the careful choice of filter type. The traces of heparin (mol wt 17 500) which inevitably pass through the desalting column prevented coagulation in the plasma-diluted 1251 fibrinogen preparation.
The material and equipment required for the extraction are readily available in hospital laboratories and it is possible to produce pure material simply in a very short time. A 'kit' for the production of this radiopharmaceutical, including the 'separation vessel' combined desalting/sterilizing apparatus, and all necessary buffers is at present being tested. 
